{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:58:56Z","timestamp":1759341536744},"reference-count":34,"publisher":"Japanese Society of Hypertension","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1291\/hypres.31.1669","type":"journal-article","created":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T01:58:16Z","timestamp":1225331896000},"page":"1669-1675","source":"Crossref","is-referenced-by-count":7,"title":["A Case of Primary Aldosteronism Associated with Renal Artery Stenosis and Preclinical Cushing's Syndrome"],"prefix":"10.1291","volume":"31","author":[{"given":"Kazuo","family":"TSUNODA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"ABE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"YAMADA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"KATO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiraku","family":"YAOITA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"TAGUMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"GOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomasa","family":"IORIDANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Preston RA, Epstein M: Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. <i>J Hypertens<\/i> 1997; <b>5<\/b>: 1365-1377.","DOI":"10.1097\/00004872-199715120-00001"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02583034"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hoet JJ, Molineaux L: Conn&rsquo;s syndrome: the effect of amphenone. <i>Acta Endocrinol<\/i> 1960; <b>33<\/b>: 375-387.","DOI":"10.1530\/acta.0.XXXIII0375"},{"key":"4","unstructured":"4. Laidlaw JC, Yendt ER, Gornall A: Hypertension caused by renal artery occlusion simulating primary aldosteronism. <i>Metabolism<\/i> 1960; <b>9<\/b>: 612-623."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Bloch HS: Hypertension, bilateral renal artery stenosis, adrenocortical adenomas, and normal serum electrolyte levels. <i>JAMA<\/i> 1966; <b>196<\/b>: 622-624.","DOI":"10.1001\/jama.196.7.622"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Christenson WB, Kauiman JJ, Gonick HC: Co-existing aldosterone-producing adrenal tumor (aldosteronoma) and bilateral renovascular lesions. <i>J Urol<\/i> 1969; <b>101<\/b>: 1-7.","DOI":"10.1016\/S0022-5347(17)62258-4"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mills IH, Cook RF, Galley JM, Edwards OM, Tait AD: Corticosterone-secreting tumors: with and without renal artery stenosis. <i>Clin Endocrinol<\/i> 1980; <b>13<\/b>: 355-360.","DOI":"10.1111\/j.1365-2265.1980.tb03396.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Vircburger MI, Prelevic GM, Todorovic P, Bojic P, Peric LA, Paunkovic N: Renovscular hypertension associated with bilateral aldosteronoma. <i>Postgrad Med J<\/i> 1984; <b>60<\/b>: 533-536.","DOI":"10.1136\/pgmj.60.706.533"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Santangelo K, Cheung JY, Gifford RR, Thiele BL, Yang HC: The simultaneous occurrence of renal artery stenosis and an aldosteronoma in a patient with hypertension. <i>Am J Kidney Dis<\/i> 1989; <b>14<\/b>: 520-523.","DOI":"10.1016\/S0272-6386(89)80154-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Takenaka T, Nishikawa A, Nakahara K, Hattori S, Yokokawa T, Izawa A: A case of primary aldosteronism with renovascular hypertension. <i>Jpn J Med<\/i> 1990; <b>4<\/b>: 429-432.","DOI":"10.2169\/internalmedicine1962.29.429"},{"key":"11","unstructured":"11. Ghilardi G, Pizzocari P, Bortolani E, Monti M DE, Longhi F: The concomitance of renal artery stenosis and Conn&rsquo;s adenoma in a hypertensive woman. <i>Panminerva Med<\/i> 1991; <b>33<\/b>: 53-56."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Cheung YK, Chan FL, Lam KSL: Aldosteronoma coexisting with renal artery stenosis in secondary hypertension. <i>Urol Radiol<\/i> 1992; <b>13<\/b>: 228-232.","DOI":"10.1007\/BF02924629"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1992.tb00457.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chowdhury TA, Lasker SS: Coexisting renal artery stenosis and primary aldosteronism. <i>Nephrol Dial Transplant<\/i> 1997; <b>12<\/b>: 2735-2736.","DOI":"10.1093\/ndt\/12.12.2735"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mattix H, Dennard DT, Hall D: Fibromuscular dysplasia of the renal artery and adrenal adenoma in a 36-year-old woman with hypertension. <i>Am J Med Sci<\/i> 1997; <b>314<\/b>: 51-53.","DOI":"10.1097\/00000441-199707000-00012"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Mansoor GA, Tendler BE, Anwar YA, Uwaifo G, White WB: Coexistence of atherosclerotic renal artery stenosis with primary hyperaldosteronism. <i>J Hum Hyperens<\/i> 2000; <b>14<\/b>: 151-153.","DOI":"10.1038\/sj.jhh.1000950"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Glodny B, Cromme S, Wortler K, Herwig R, Kisters K, Winde G: Conn&rsquo;s syndrome and bilatelal renal artery stenosis in the presence of multiple renal arteries. <i>J Endocrinol Invest<\/i> 2001; <b>24<\/b>: 268-273.","DOI":"10.1007\/BF03343857"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Karagiannis A, Tziomalos K, Dona K, <i>et al<\/i>: Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient. <i>QJM<\/i> 2005; <b>98<\/b>: 913-918.","DOI":"10.1093\/qjmed\/hci143"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Pizzolo F, Pavan C, Guarini P, <i>et al<\/i>: Primary hyperaldosteronism: a frequent cause of residual hypertension after successful endovascular treatment of renal artery disease. <i>J Hypertens<\/i> 2005; <b>23<\/b>: 2041-2047.","DOI":"10.1097\/01.hjh.0000187260.32567.75"},{"key":"20","unstructured":"20. Tanemoto M, Honkura K, Abe M, Satoh F, Abe T, Ito S: Aldosterone-producing adenoma accompanied with renal artery stenosis. <i>J Nephrol<\/i> 2006; <b>19<\/b>: 540-542."},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.24.723"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.48.103"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)93002-3"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1000785"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Stowasser M, Gordon RD: Prevalence and diagnostic workup of primary aldosteronism: new knowledge and new approaches. <i>Nephrology<\/i> 2001; <b>6<\/b>: 119-126.","DOI":"10.1046\/j.1440-1797.2001.00040.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Young WF: Minireview: primary aldosteronism&mdash;changing concepts in diagnosis and treatment. <i>Endocrinology<\/i> 2003; <b>114<\/b>: 2208-2213.","DOI":"10.1210\/en.2003-0279"},{"key":"27","unstructured":"27. Beevers DG, Brown JJ, Ferriss JB, <i>et al<\/i>: Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertialy hyperaldosteronism. <i>QJM<\/i> 1976; <b>179<\/b>: 401-410."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Grim C, Weinberger M, Higgins J, Kramer N: Diagnosis of secondary forms of hypertension: a comprehensive protocol. <i>JAMA<\/i> 1977; <b>237<\/b>: 1331-1335.","DOI":"10.1001\/jama.237.13.1331"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Kurzman NA, Pillay VK, Rogers PW, Nash D Jr: Renal vascular hypertension and low plasma renin activity. Interrelationship of volume and renin in the pathogenesis of hypertension. <i>Arch Intern Med<\/i> 1974; <b>133<\/b>: 195-199.","DOI":"10.1001\/archinte.133.2.195"},{"key":"30","unstructured":"30. Baer L, Sommers SC, Krakoff LR, Newton MA, Laragh JH: Pseudo-primary aldosteronism. An entity distinct from true primary aldosteronism. <i>Circ Res<\/i> 1970; <b>27<\/b> (Suppl 1): 203-220."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Conn JW, Cohen EL, Lucas CP, <i>et al<\/i>: Primary reninism. <i>Arch Intern Med<\/i> 1972; <b>130<\/b>: 682-696.","DOI":"10.1001\/archinte.130.5.682"},{"key":"32","unstructured":"32. Tsunoda K, Imai Y, Omata K, <i>et al<\/i>: Long-term follow-up study of 90 cases of surgically treated aldosterone-producing adenoma. <i>J Jpn Coll Angiol<\/i> 1993; <b>33<\/b>: 149-153."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Suzuki T, Sasano H, Sawai T, <i>et al<\/i>: Small adrenocortical tumors without clinical apparent clinical endocrine abnormalities. <i>Path Res Prac<\/i> 1992; <b>188<\/b>: 883-889.","DOI":"10.1016\/S0344-0338(11)80248-7"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.179.123"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T20:30:16Z","timestamp":1557865816000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.31.1669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.31.1669","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}